Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...

We provide a methodology for selecting high-growth dividend stocks, focusing on dividend growth and sustainability rather ...

NBCC: The company has successfully sold 446 residential units at Aspire Silicon City in Noida through an e-auction, generating Rs 1,468 crore in sales. Additionally, it will receive a marketing fee of ...

Foreign portfolio investors remained net buyers of Indian equities for the third straight day on Friday, as they mopped up equities worth Rs 8,831.1 crore, the highest since March 27, according to the ...

Shares of Pfizer Ltd are in news today rose after the firm reported a stellar set of Q4 earnings. The pharma firm reported a ...

How many shares of Pfizer should you own to make $10,000 in annual dividend income? Where to invest $1,000 right now? Our ...

Pfizer has signed a licensing agreement worth up to $6 billion with Chinese pharmaceutical products developer 3SBio Inc for ...

Pfizer stated that the drug candidate, which is being evaluated for non-small cell lung cancer, metastatic colorectal cancer ...

If you really want to get exactly $10,000 in annual dividend income, though, you could use fractional shares. At Pfizer's share price at the time of this writing ($22.87), you'd need to invest ...

For investors willing to look beyond the current negative sentiment, Pfizer at today's prices represents a rare buying ...

Pharmaceutical stocks, including Pfizer (NYSE: PFE) have recently come under scrutiny following President Trump’s executive order directing drugmakers to lower medicine prices to match what ...